Biotech Values

[DewDiligence]

>Kunath filed 4 form 4's over a several day period<

That’s correct, although one of these filings was a Form-4/A to amend a prior Form-4.

The relevant point here is that Kunath still owns quite a few options (13,200 exercisable @1.81 from the Form-4 I cited and 12,000 exercisable @4.41 from the Form-4/A filed on Apr 17). These options can be exercised and sold in subsequent 10b5-1 transactions.